Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin

Uncertainty regarding an optimal antiplatelet regimen still exists in patients with breakthrough acute ischemic stroke (AIS) while on aspirin. This study provides an analysis of a prospective multicenter registry between April 2008 and April 2014. Eligible patients were on aspirin at the time of AIS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joon-Tae, Kim, Beom Joon, Park, Jong-Moo, Lee, Soo Joo, Cha, Jae-Kwan, Park, Tai Hwan, Lee, Kyung Bok, Lee, Jun, Hong, Keun-Sik, Lee, Byung-Chul, Kim, Dong-Eog, Choi, Jay Chol, Kwon, Jee-Hyun, Shin, Dong-Ick, Sohn, Sung Il, Lee, Ji Sung, Lee, Juneyoung, Bae, Hee-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541489/
https://www.ncbi.nlm.nih.gov/pubmed/33028887
http://dx.doi.org/10.1038/s41598-020-73836-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541489/
https://www.ncbi.nlm.nih.gov/pubmed/33028887
http://dx.doi.org/10.1038/s41598-020-73836-0

Ejemplares similares